Cited by 47Gut microbiota and healthAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

The Gut Microbiota-Brain Axis during Aging, Mild Cognitive Impairment and Dementia: Role of Tau Protein, β-Amyloid and LPS in Serum and Curli Protein in Stool

Open access
Sánchez-Tapia, Mónica, Mimenza-Alvarado, Alberto, Granados-Domínguez, Lizbeth, Flores-López, Adriana, López-Barradas, Adriana, Ortiz, Victor, Pérez-Cruz, Claudia, Sánchez-Vidal, Hilda +5 more·2023·Nutrients

Abstract

Currently, there is an increasing number of people with mild cognitive (MCI) impairment and dementia (D). In the present work we studied the role of tau protein, β-amyloid, LPS (lipopolysaccharide), and curli protein of elderly adults with MCI or D and the contribution of gut microbiota. Four groups were studied: young subjects, healthy adults older than 60 years (A), elderly adults with MCI (MCI), and elderly adults with dementia (D). A preclinical study was conducted in old male Wistar rats to evaluate the impact of gut microbiota on curli protein abundance in feces and brain. The results showed that with increasing age, tau protein, β-amyloid, and LPS significantly increased in serum during MCI and D, and this was associated with an increase in the abundance of E. coli that synthesize the amyloid protein curli, that may promote the aggregation of amyloid proteins. Rats showed a clear increase in the abundance of curli protein in the brain during aging. Thus, cognitive impairment and dementia are in part due to an alteration in the gut microbiota–brain axis via increase in curli protein and LPS leading to an increase in tau and β-amyloid protein.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu15040932

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • LPS is elevated in both the blood and brain of AD patients.

    “LPS is elevated in both the blood and brain of AD patients.25–29”

    From TET2-mutant myeloid cells mitigate Alzheimer’s disease progression via CNS infiltration and enhanced phagocytosis in mice (2025) · cites this paper as [29]

    Results §3.2 and the Discussion report substantially higher serum LPS in the dementia group than in healthy controls, supporting the blood portion of the claim. Methods §2.7 says LPS was measured in serum; the paper does not report elevated LPS in patients’ brains. Its studied group is described as having dementia, not specifically diagnosed AD. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 28 · Cited by 47

Research works printed but not linked: 19

  1. [1]Livingston G. Sommerlad A. Orgeta V. Costafreda S.G. Huntley J. Ames D. Ballard C. Banerjee S. Burns A. Cohen-Mansfield J. Dementia prevention, intervention, and care Lancet 2017 390 2673 2734 10.1016/S0140-6736(17)31363-6 28735855 · DOI · Paper page
  2. [2]Prince M.J. Wu F. Guo Y. Gutierrez Robledo L.M. O’Donnell M. Sullivan R. Yusuf S. The burden of disease in older people and implications for health policy and practice Lancet 2015 385 549 562 10.1016/S0140-6736(14)61347-7 25468153 · DOI
  3. [3]Ferrucci L. Fabbri E. Inflammageing: Chronic inflammation in ageing, cardiovascular disease, and frailty Nat. Rev. Cardiol. 2018 15 505 522 10.1038/s41569-018-0064-2 30065258 PMC6146930 · DOI · Paper page
  4. [4]Alzheimer’s A. 2015 Alzheimer’s disease facts and figures Alzheimer’s Dement. 2015 11 332 384 10.1016/j.jalz.2015.02.003 25984581 · DOI
  5. [5]Lee J.W. Lee Y.K. Yuk D.Y. Choi D.Y. Ban S.B. Oh K.W. Hong J.T. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation J. Neuroinflamm. 2008 5 37 10.1186/1742-2094-5-37 PMC2556656 18759972 · DOI · Paper page
  6. [7]Schwartz K. Boles B.R. Microbial amyloids--functions and interactions within the host Curr. Opin. Microbiol. 2013 16 93 99 10.1016/j.mib.2012.12.001 23313395 PMC3622111 · DOI
  7. [9]Zhu S. Jiang Y. Xu K. Cui M. Ye W. Zhao G. Jin L. Chen X. The progress of gut microbiome research related to brain disorders J. Neuroinflamm. 2020 17 25 10.1186/s12974-020-1705-z PMC6969442 31952509 · DOI · Paper page
  8. [11]Tillisch K. The effects of gut microbiota on CNS function in humans Gut Microbes 2014 5 404 410 10.4161/gmic.29232 24838095 PMC4153780 · DOI · Paper page
  9. [12]Lambert J.C. Ibrahim-Verbaas C.A. Harold D. Naj A.C. Sims R. Bellenguez C. DeStafano A.L. Bis J.C. Beecham G.W. Grenier-Boley B. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease Nat. Genet. 2013 45 1452 1458 10.1038/ng.2802 24162737 PMC3896259 · DOI · Paper page
  10. [13]Reitz C. Brayne C. Mayeux R. Epidemiology of Alzheimer disease Nat. Rev. Neurol. 2011 7 137 152 10.1038/nrneurol.2011.2 21304480 PMC3339565 · DOI · Paper page
  11. [14]Daulatzai M.A. Role of stress, depression, and aging in cognitive decline and Alzheimer’s disease Curr. Top. Behav. Neurosci. 2014 18 265 296 10.1007/7854_2014_350 25167923 · DOI
  12. [15]Zhou Y. Smith D.R. Hufnagel D.A. Chapman M.R. Experimental manipulation of the microbial functional amyloid called curli Methods Mol. Biol. 2013 966 53 75 10.1007/978-1-62703-245-2_4 23299728 PMC3773212 · DOI
  13. [16]Biagi E. Candela M. Fairweather-Tait S. Franceschi C. Brigidi P. Aging of the human metaorganism: The microbial counterpart Age 2012 34 247 267 10.1007/s11357-011-9217-5 21347607 PMC3260362 · DOI
  14. [17]Medina-Vera I. Sanchez-Tapia M. Noriega-Lopez L. Granados-Portillo O. Guevara-Cruz M. Flores-Lopez A. Avila-Nava A. Fernandez M.L. Tovar A.R. Torres N. A dietary intervention with functional foods reduces metabolic endotoxaemia and attenuates biochemical abnormalities by modifying faecal microbiota in people with type 2 diabetes Diabetes Metab. 2019 45 122 131 10.1016/j.diabet.2018.09.004 30266575 · DOI
  15. [18]Langille M.G. Zaneveld J. Caporaso J.G. McDonald D. Knights D. Reyes J.A. Clemente J.C. Burkepile D.E. Vega Thurber R.L. Knight R. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences Nat. Biotechnol. 2013 31 814 821 10.1038/nbt.2676 23975157 PMC3819121 · DOI · Paper page
  16. [19]O’Mahony S.M. Clarke G. Borre Y.E. Dinan T.G. Cryan J.F. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis Behav. Brain Res. 2015 277 32 48 10.1016/j.bbr.2014.07.027 25078296 · DOI · Paper page
  17. [21]Fischer R. Maier O. Interrelation of oxidative stress and inflammation in neurodegenerative disease: Role of TNF Oxidative Med. Cell. Longev. 2015 2015 610813 10.1155/2015/610813 25834699 PMC4365363 · DOI
  18. [24]Kowalski K. Mulak A. Brain-Gut-Microbiota Axis in Alzheimer’s Disease J. Neurogastroenterol. Motil. 2019 25 48 60 10.5056/jnm18087 30646475 PMC6326209 · DOI · Paper page
  19. [26]Sokol H. Pigneur B. Watterlot L. Lakhdari O. Bermudez-Humaran L.G. Gratadoux J.J. Blugeon S. Bridonneau C. Furet J.P. Corthier G. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients Proc. Natl. Acad. Sci. USA 2008 105 16731 16736 10.1073/pnas.0804812105 18936492 PMC2575488 · DOI · Paper page

Authors
Sánchez-Tapia, M., Mimenza-Alvarado, A., Granados-Domínguez, L., Flores-López, A., López-Barradas, A., Ortiz, V., Pérez-Cruz, C., Sánchez-Vidal, H., Hernández-Acosta, J., Ávila-Funes, J. A., Guevara-Cruz, M., Tovar, A. R., & Torres, N.
Affiliations
  • Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Av. Vasco de Quiroga No. 15, Col. Belisario Domínguez, Sección XVI, Tlalpan, Mexico City 14080, Mexico
  • Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX)
  • Laboratorio de Neuroplasticidad y Neurodegeneración, Departamento de Farmacología, CINVESTAV, Mexico City 07360, Mexico
  • Departamento de Geriatria, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico
Corresponding author
Torres, Nimbe
Venue
Nutrients
Publisher
MDPI AG
Published
2023-02-13
Volume
15
Issue
4
Pages
932
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4320497552
Cited by
47
References
28
Citations by year
2026: 10 · 2025: 21 · 2024: 14 · 2023: 2
FWCI
4.19
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
gut-brain axis, aging, mild cognitive impairment, dementia, tau protein, amyloid-beta, lipopolysaccharide, Escherichia coli, amyloid fibril formation, serum biomarkers, fecal microbiota, brain amyloid, cognitive impairment
MeSH terms
Gastrointestinal Microbiome, Aging, Alzheimer Disease, Animals, Brain, Escherichia coli, Feces, Lipopolysaccharides, Male, Amyloid beta-Peptides, Rats, Wistar, Rats, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review